186454-70-6

Basic information

• Product Name: Furo[2,3-d]pyrimidin-4-amine (9CI)
• Synonyms: Furo[2,3-d]pyrimidin-4-amine (9CI);4-Aminofuro[2,3-d]pyrimidine;Furo[2,3-d]pyrimidin-4-amine;furo[3,2-d]pyrimidin-4-amine
• CAS NO: 186454-70-6
• Molecular Formula: C₆H₅N₃O
• Molecular Weight: 135.1234
• Product Categories: PYRIMIDINE
• Mol File: 186454-70-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 291 ºC
• Flash Point: 130 ºC
• Appearance: /
• Density: 1.421
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.702
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: Furo[2,3-d]pyrimidin-4-amine (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Furo[2,3-d]pyrimidin-4-amine (9CI)(186454-70-6)
• EPA Substance Registry System: Furo[2,3-d]pyrimidin-4-amine (9CI)(186454-70-6)

Safety Data

• Hazardous Substances Data: 186454-70-6(Hazardous Substances Data)

Usage

General Description

Furo[2,3-d]pyrimidin-4-amine (9CI) is a chemical compound with the molecular formula C6H5N3O. It is a heterocyclic aromatic amine with a furo[2,3-d]pyrimidine ring system, which makes it useful in pharmaceutical and agrochemical applications. Furo[2,3-d]pyrimidin-4-amine (9CI) has potential as a building block in the synthesis of various biologically active molecules, including anticancer and antiviral agents. It is also used as a precursor in the production of dyes and pigments, as well as in the development of new materials for electronic and optoelectronic devices. Furo[2,3-d]pyrimidin-4-amine (9CI) is a versatile chemical that has a wide range of potential applications in various industries.

InChI:InChI=1/C6H5N3O/c7-5-4-1-2-10-6(4)9-3-8-5/h1-3H,(H2,7,8,9)

Upstream product

• 139370-56-2 2-aminofuran-3-carbonitrile 
• 77287-34-4 formamide 
• 23147-58-2 glycolaldehyde dimer 

Downstream Products

• 918340-57-5 2-chloro-5-(furo[2,3-d]pyrimidin-4-ylamino)-phenol 
• 918340-51-9 4-chlorofuro[2,3,d]pyrimidine 

Relevant articles and documents

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

The present invention provides, in part, compounds of Formula (I) and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1 -associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), schizotypal personality disorder, cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), ADHD, Parkinson's disease, anxiety, and depression.

NOVEL CHEMICAL COMPOUNDS

The present invention relates generally to inhibitors of the kinases, such as GSK-3, and more particularly to fused pyrimidine compounds.